Montelukast in the treatment of asthma and beyond. - Wikidata - wikimedia - TriplyDB

Montelukast in the treatment of asthma and beyond.

Montelukast in the treatment of asthma and beyond.

http://www.wikidata.org/entity/Q37755326

about

Regulation of dendritic cell functions against harmful respiratory pathogens by a cysteinyl leukotrienes receptor antagonist.Therapeutic options for severe asthma A comparison of confounding adjustment methods for assessment of asthma controller medication effectiveness Airway remodeling: a potential therapeutic target in asthma.Montelukast for the treatment of asthma in the adult population.Emerging drugs for asthma.Leukotriene receptor antagonists pranlukast and montelukast for treating asthma.Pharmacotherapy for the treatment of asthma: current treatment options and future directions.Cysteinyl Leukotriene Receptor 1/2 Antagonists Nonselectively Modulate Organic Anion Transport by Multidrug Resistance Proteins (MRP1-4).Exhaled nitric oxide in childhood allergic asthma management: a randomised controlled trial.Lack of activity of 15-epi-lipoxin A₄ on FPR2/ALX and CysLT1 receptors in interleukin-8-driven human neutrophil function.Response to the Editor: "Fractional exhaled nitric oxide-guided algorithm for children with allergic asthma".

P2860

Q36114464-C0F44675-CCBE-4905-98C1-FAB3DF6E5547 Q36286252-FD2FE496-D214-417C-A10E-F4A1362179E0 Q37697471-654B6D6A-799C-485C-9BF0-3C2DE7753F47 Q37875805-8EB9724B-D55B-4AC1-980D-CC270D366A8B Q37903337-94513D30-198D-4C8A-95B8-5E0BCD4061FD Q38011270-5BCE2972-3CAA-44B8-9F74-6C453F28B5EB Q38172278-782B1D58-45F6-4981-AFB2-D7BDC53E1A8A Q38579908-B56BE6F5-D2F3-4AD2-9472-E242D75CEE46 Q45348897-1E40C210-A04A-415F-B59E-0B40BB53C425 Q45417486-BFE2F349-0A42-4144-8866-E1844EDD9C9F Q46062576-CBB67141-5A76-4AF6-809E-289B1B7A3CB7 Q51001476-C55AFC86-F3C5-4653-B3C8-6F54A5985BC6

P2860

Montelukast in the treatment of asthma and beyond.

http://www.wikidata.org/entity/Q37755326

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Montelukast in the treatment of asthma and beyond.

@en

Montelukast in the treatment of asthma and beyond.

@nl

type

label

Montelukast in the treatment of asthma and beyond.

@en

Montelukast in the treatment of asthma and beyond.

@nl

prefLabel

Montelukast in the treatment of asthma and beyond.

@en

Montelukast in the treatment of asthma and beyond.

@nl

P1433

Q37755326-0EC33AC4-DEAC-4514-B8B9-15B1B793853C

P1476

Q37755326-CC5DA4C8-F619-499C-BA37-2C667ABF82B1

P2093

Q37755326-6C44CCD9-67D1-4B43-9DED-078C57E2D4B5

Q37755326-C9264775-6CAC-43CC-AC45-D9C461D51AD8

P2860

Q37755326-0226E607-A47A-47E3-8B38-52B8F447D360

Q37755326-02440C68-CF85-4B7B-8ED5-EFA92B0CE26F

Q37755326-031DECD6-5F32-4ED0-AB77-3356B22C297C

Q37755326-03F11521-DF54-4C08-9354-57F27406F582

Q37755326-08D480FB-6B5A-43CA-90C1-1F7B1AE00E1F

Q37755326-0B996D84-2A9F-4C7B-90AE-107C317BA1AB

Q37755326-0C64189D-F7DE-464C-B738-FED18FB26F82

Q37755326-0E745DF0-9179-4A5D-A8C0-E2F6616ED8B4

Q37755326-11D40BBA-D497-4EF4-B008-D7E5B9303D0D

Q37755326-1457D17C-1757-476E-B1BF-C19B608981C5

P304

Q37755326-778AEE21-3EBC-445C-AEB6-49CF91192278

P31

Q37755326-506D2740-0CCB-49F8-9309-803CF9520EEF

P356

Q37755326-1681E1BF-DCF2-43D6-B5E6-7D4B60951C0D

P433

Q37755326-45565747-8F05-4FA6-A3F7-18C40FC6262A

P478

Q37755326-2241546E-F58E-464E-8247-A13203F070C0

P50

Q37755326-9C07A080-F27C-4F33-9E4C-DE32925F185D

P577

Q37755326-6F564DEA-03AA-4AD6-AEB1-8F69D2739060

P5875

Q37755326-14707E12-122F-4445-B67D-F340033B82FA

P698

Q37755326-8FA9F42C-0410-41AE-951C-14D0300A2EA7

P921

Q37755326-3B5F43AE-FE14-437D-8A9E-9714FFB00341

P356

P1433

Expert Review of Clinical Immunology

P1476

Montelukast in the treatment of asthma and beyond.

@en

P2093

Eva Mantzouranis

http://www.w3.org/2001/XMLSchema#string

Zuzana Diamant

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of the human cysteinyl leukotriene CysLT1 receptor

Bronchial mast cells are the dominating LTC4S-expressing cells in aspirin-tolerant asthma

Transgenic smooth muscle expression of the human CysLT1 receptor induces enhanced responsiveness of murine airways to leukotriene D4

Characterization of within-subject responses to fluticasone and montelukast in childhood asthma

The global burden of asthma: executive summary of the GINA Dissemination Committee report

Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged > or = 6 years.

The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma.

The expanding role of leukotriene receptor antagonists in chronic asthma.

Rates of asthma attacks in patients with previously inadequately controlled mild asthma treated in clinical practice with combination drug therapy: an exploratory post-hoc analysis.

History and future perspectives of treating asthma as a systemic and small airways disease.

P304

639-658

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ECI.09.62

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44606744

http://www.w3.org/2001/XMLSchema#string

P698

20477688

http://www.w3.org/2001/XMLSchema#string

P921